LPAR1 and arthritic joint disease: Treatment of mice with an LPA1 antagonist (Miyabe et al., 2013; Orosa et al., 2014) or genetic ablation of ATX in synovial fibroblasts (Nikitopoulou et al., 2012) reduced the severity of arthritis.